Диссертация (1140892), страница 21
Текст из файла (страница 21)
‒ T. 77, № 6. ‒ C. 1261-1270.38. Horny H. P., Parwaresch M. R., Lennert K. Bone marrow findings in systemic mastocytosis // HumPathol. ‒ 1985. ‒ T. 16, № 8. ‒ C. 808-14.39. Valent P., Akin C., Sperr W. R., Horny H. P., Arock M., Lechner K., Bennett J. M., Metcalfe D. D.Diagnosis and treatment of systemic mastocytosis: state of the art // Br J Haematol. ‒ 2003. ‒T. 122, № 5. ‒ C. 695-717.40. Metcalfe D. D. Mast cells and mastocytosis // Blood. ‒ 2008. ‒ T.
112, № 4. ‒ C. 946-56.13041. Parwaresch M. R., Horny H. P., Lennert K. Tissue mast cells in health and disease // Pathol ResPract. ‒ 1985. ‒ T. 179, № 4-5. ‒ C. 439-61.42. Bodemer C., Hermine O., Palmerini F., Yang Y., Grandpeix-Guyodo C., Leventhal P. S., HadjRabia S., Nasca L., Georgin-Lavialle S., Cohen-Akenine A., Launay J. M., Barete S., Feger F.,Arock M., Catteau B., Sans B., Stalder J. F., Skowron F., Thomas L., Lorette G., Plantin P.,Bordigoni P., Lortholary O., de Prost Y., Moussy A., Sobol H., Dubreuil P. Pediatricmastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations //J Invest Dermatol.
‒ 2010. ‒ T. 130, № 3. ‒ C. 804-15.43. Garcia-Montero A. C., Jara-Acevedo M., Teodosio C., Sanchez M. L., Nunez R., Prados A.,Aldanondo I., Sanchez L., Dominguez M., Botana L. M., Sanchez-Jimenez F., Sotlar K.,Almeida J., Escribano L., Orfao A. KIT mutation in mast cells and other bone marrowhematopoietic cell lineages in systemic mast cell disorders: a prospective study of the SpanishNetwork on Mastocytosis (REMA) in a series of 113 patients // Blood. ‒ 2006. ‒ T.
108, № 7.‒ C. 2366-72.44. Ellis J. M. Urticaria pigmentosa; a report of a case with autopsy // Arch Pathol (Chic). ‒ 1949. ‒ T.48, № 5. ‒ C. 426-35.45. Nagata H., Worobec A. S., Oh C. K., Chowdhury B. A., Tannenbaum S., Suzuki Y., Metcalfe D.D. Identification of a point mutation in the catalytic domain of the protooncogene c-kit inperipheral blood mononuclear cells of patients who have mastocytosis with an associatedhematologic disorder // Proc Natl Acad Sci U S A. ‒ 1995. ‒ T.
92, № 23. ‒ C. 10560-4.46. Longley B. J., Tyrrell L., Lu S. Z., Ma Y. S., Langley K., Ding T. G., Duffy T., Jacobs P., Tang L.H., Modlin I. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressivemastocytosis: establishment of clonality in a human mast cell neoplasm // Nat Genet. ‒ 1996. ‒T. 12, № 3. ‒ C.
312-4.47. Horny H. P., Sillaber C., Menke D., Kaiserling E., Wehrmann M., Stehberger B., Chott A.,Lechner K., Lennert K., Valent P. Diagnostic value of immunostaining for tryptase in patientswith mastocytosis // Am J Surg Pathol. ‒ 1998. ‒ T. 22, № 9. ‒ C. 1132-40.48. Escribano L., Orfao A., Diaz-Agustin B., Villarrubia J., Cervero C., Lopez A., Marcos M. A.,Bellas C., Fernandez-Canadas S., Cuevas M., Sanchez A., Velasco J.
L., Navarro J. L., MiguelJ. F. Indolent systemic mast cell disease in adults: immunophenotypic characterization of bonemarrow mast cells and its diagnostic implications // Blood. ‒ 1998. ‒ T. 91, № 8. ‒ C. 2731-6.49. Schwartz L. B., Irani A. M. Serum tryptase and the laboratory diagnosis of systemic mastocytosis// Hematol Oncol Clin North Am. ‒ 2000. ‒ T. 14, № 3. ‒ C. 641-57.13150. Sperr W. R., Escribano L., Jordan J.
H., Schernthaner G. H., Kundi M., Horny H. P., Valent P.Morphologic properties of neoplastic mast cells: delineation of stages of maturation andimplication for cytological grading of mastocytosis // Leuk Res. ‒ 2001. ‒ T. 25, № 7. ‒ C.529-36.51. Valent P., Escribano L., Parwaresch R. M., Schemmel V., Schwartz L. B., Sotlar K., Sperr W. R.,Horny H.
P. Recent advances in mastocytosis research. Summary of the Vienna MastocytosisMeeting 1998 // Int Arch Allergy Immunol. ‒ 1999. ‒ T. 120, № 1. ‒ C. 1-7.52. Arber D. A., Orazi A., Hasserjian R., Thiele J., Borowitz M. J., Le Beau M. M., Bloomfield C. D.,Cazzola M., Vardiman J.
W. The 2016 revision to the World Health Organizationclassification of myeloid neoplasms and acute leukemia // Blood. ‒ 2016. ‒ T. 127, № 20. ‒ C.2391-405.53. Brockow K. Epidemiology, prognosis, and risk factors in mastocytosis // Immunol Allergy ClinNorth Am. ‒ 2014. ‒ T. 34, № 2. ‒ C. 283-95.54. De la Hoz B., Gonzalez de Olano D., Alvarez I., Sanchez L., Nunez R., Sanchez I., Escribano L.[Guidelines for the diagnosis, treatment and management of mastocytosis] // An Sist SanitNavar.
‒ 2008. ‒ T. 31, № 1. ‒ C. 11-32.55. Matito A., Alvarez-Twose I., Morgado J. M., Sanchez-Munoz L., Orfao A., Escribano L. Clinicalimpact of pregnancy in mastocytosis: a study of the Spanish Network on Mastocytosis(REMA) in 45 cases // Int Arch Allergy Immunol. ‒ 2011. ‒ T. 156, № 1. ‒ C. 104-11.56. Meni C., Bruneau J., Georgin-Lavialle S., Le Sache de Peufeilhoux L., Damaj G., Hadj-Rabia S.,Fraitag S., Dubreuil P., Hermine O., Bodemer C. Paediatric mastocytosis: a systematic reviewof 1747 cases // Br J Dermatol. ‒ 2015.
‒ T. 172, № 3. ‒ C. 642-51.57. Fett N. M., Teng J., Longley B. J. Familial urticaria pigmentosa: report of a family and review ofthe role of KIT mutations // Am J Dermatopathol. ‒ 2013. ‒ T. 35, № 1. ‒ C. 113-6.58. Jennings S., Russell N., Jennings B., Slee V., Sterling L., Castells M., Valent P., Akin C. TheMastocytosis Society survey on mast cell disorders: patient experiences and perceptions // JAllergy Clin Immunol Pract. ‒ 2014. ‒ T.
2, № 1. ‒ C. 70-6.59. Hermine O., Lortholary O., Leventhal P. S., Catteau A., Soppelsa F., Baude C., Cohen-Akenine A.,Palmerini F., Hanssens K., Yang Y., Sobol H., Fraytag S., Ghez D., Suarez F., Barete S.,Casassus P., Sans B., Arock M., Kinet J. P., Dubreuil P., Moussy A. Case-control cohort studyof patients' perceptions of disability in mastocytosis // PLoS One. ‒ 2008. ‒ T. 3, № 5. ‒ C.e2266.60.
Hartmann K., Metcalfe D. D. Pediatric mastocytosis // Hematol Oncol Clin North Am. ‒ 2000. ‒ T.14, № 3. ‒ C. 625-40.13261. Wiechers T., Rabenhorst A., Schick T., Preussner L. M., Forster A., Valent P., Horny H. P., SotlarK., Hartmann K. Large maculopapular cutaneous lesions are associated with favorableoutcome in childhood-onset mastocytosis // J Allergy Clin Immunol. ‒ 2015. ‒ T.
136, № 6. ‒C. 1581-1590 e3.62. Akin C., Valent P. Diagnostic criteria and classification of mastocytosis in 2014 // ImmunolAllergy Clin North Am. ‒ 2014. ‒ T. 34, № 2. ‒ C. 207-18.63. Valent P., Arock M., Bonadonna P., Brockow K., Broesby-Olsen S., Escribano L., Gleixner K. V.,Grattan C., Hadzijusufovic E., Hagglund H., Hermine O., Horny H.
P., Kluin-Nelemans H. C.,Maurer M., Niedoszytko M., Nedoszytko B., Nilsson G., Oude-Elberink H. N., Orfao A.,Radia D., Reiter A., Siebenhaar F., Sotlar K., Sperr W. R., Triggiani M., VanDoormaal J. J.,Varkonyi J., Yavuz S., Hartmann K. European Competence Network on Mastocytosis(ECNM): 10-year jubilee, update, and future perspectives // Wien Klin Wochenschr. ‒ 2012. ‒T. 124, № 23-24. ‒ C.
807-14.64. Akin C., Fumo G., Yavuz A. S., Lipsky P. E., Neckers L., Metcalfe D. D. A novel form ofmastocytosis associated with a transmembrane c-kit mutation and response to imatinib //Blood. ‒ 2004. ‒ T. 103, № 8. ‒ C. 3222-5.65. Alvarez-Twose I., Jara-Acevedo M., Morgado J. M., Garcia-Montero A., Sanchez-Munoz L.,Teodosio C., Matito A., Mayado A., Caldas C., Mollejo M., Orfao A., Escribano L. Clinical,immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis// J Allergy Clin Immunol. ‒ 2016. ‒ T. 137, № 1.
‒ C. 168-178 e1.66. Alvarez-Twose I., Gonzalez P., Morgado J. M., Jara-Acevedo M., Sanchez-Munoz L., Matito A.,Mollejo M., Orfao A., Escribano L. Complete response after imatinib mesylate therapy in apatient with well-differentiated systemic mastocytosis // J Clin Oncol. ‒ 2012. ‒ T. 30, № 12. ‒C. e126-9.67. Chan E. C., Bai Y., Kirshenbaum A. S., Fischer E. R., Simakova O., Bandara G., Scott L. M.,Wisch L. B., Cantave D., Carter M. C., Lewis J.
C., Noel P., Maric I., Gilfillan A. M.,Metcalfe D. D., Wilson T. M. Mastocytosis associated with a rare germline KIT K509Imutation displays a well-differentiated mast cell phenotype // J Allergy Clin Immunol. ‒ 2014.‒ T. 134, № 1. ‒ C. 178-87.68. Kitamura Y., Kanakura Y., Fujita J., Nakano T. Differentiation and transdifferentiation of mastcells; a unique member of the hematopoietic cell family // Int J Cell Cloning. ‒ 1987. ‒ T. 5, №2. ‒ C. 108-21.69. Ribatti D. The development of human mast cells. An historical reappraisal // Exp Cell Res. ‒ 2016.‒ T.
342, № 2. ‒ C. 210-5.13370. Okayama Y., Kawakami T. Development, migration, and survival of mast cells // Immunol Res. ‒2006. ‒ T. 34, № 2. ‒ C. 97-115.71. Bibi S., Langenfeld F., Jeanningros S., Brenet F., Soucie E., Hermine O., Damaj G., Dubreuil P.,Arock M. Molecular defects in mastocytosis: KIT and beyond KIT // Immunol Allergy ClinNorth Am. ‒ 2014. ‒ T. 34, № 2. ‒ C. 239-62.72. Roskoski R., Jr. Structure and regulation of Kit protein-tyrosine kinase--the stem cell factorreceptor // Biochem Biophys Res Commun. ‒ 2005. ‒ T.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
